+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Infection Surveillance Solutions - Global Market Trajectory & Analytics

  • ID: 4805792
  • Report
  • April 2021
  • Region: Global
  • 139 pages
  • Global Industry Analysts, Inc
Global Infection Surveillance Solutions Market to Reach $946.9 Million by 2027

Amid the COVID-19 crisis, the global market for Infection Surveillance Solutions estimated at US$391.3 Million in the year 2020, is projected to reach a revised size of US$946.9 Million by 2027, growing at a CAGR of 13.5% over the period 2020-2027. Software, one of the segments analyzed in the report, is projected to record 13.2% CAGR and reach US$600.7 Million by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Services segment is readjusted to a revised 14% CAGR for the next 7-year period.



The U.S. Market is Estimated at $115.6 Million, While China is Forecast to Grow at 13% CAGR

The Infection Surveillance Solutions market in the U.S. is estimated at US$115.6 Million in the year 2020. China, the world's second largest economy, is forecast to reach a projected market size of US$165.4 Million by the year 2027 trailing a CAGR of 13% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 11.8% and 11.5% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 9.9% CAGR.

Select Competitors (Total 41 Featured):
  • Atlas Medical Software
  • Baxter International, Inc.
  • Becton, Dickinson and Company
  • Deb Group Ltd.
  • Gojo Industries, Inc.
  • Hygreen, Inc.
  • Premier, Inc.
  • Rl Solutions
  • Truven Health Analytics
Note: Product cover images may vary from those shown
I. METHODOLOGY

II. EXECUTIVE SUMMARY
  • Influencer Market Insights
  • World Market Trajectories
  • Infection Surveillance Solutions Market on a Rapid Growth Trajectory
  • Cloud-based Infection Surveillance Solutions Witness Increased Demand
  • Asia-Pacific to be Fastest Growing Region, Driven by Increasing Cases of HAIs
  • Impact of Covid-19 and a Looming Global Recession
  • Growing Incidence of HAIs, and Government Measures to Control them Drive the Growth of Infection Surveillance Solutions Market
  • Increasing Emphasis on Controlling Healthcare Expenditure Propels the Infection Surveillance Solutions Market
  • Rise in Number of Surgeries to Increase the Chances of HAI, thereby Driving the Demand for Infection Surveillance Solutions
  • Increasing Automation in Healthcare Units Offer Significant Opportunities for Market Growth
  • Table 1: World Current & Future Analysis for Infection Surveillance Solutions by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
  • Table 2: World 7-Year Perspective for Infection Surveillance Solutions by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2020 & 2027
  • Table 3: World Current & Future Analysis for Software by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
  • Table 4: World 7-Year Perspective for Software by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027
  • Table 5: World Current & Future Analysis for Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
  • Table 6: World 7-Year Perspective for Services by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027
  • Table 7: World Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
  • Table 8: World 7-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027
  • Table 9: World Current & Future Analysis for Long-term Care Facilities by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
  • Table 10: World 7-Year Perspective for Long-term Care Facilities by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027
  • Table 11: World Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
  • Table 12: World 7-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027
III. MARKET ANALYSIS
  • Active Players in United States
  • Table 13: USA Current & Future Analysis for Infection Surveillance Solutions by Product - Software and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • Table 14: USA 7-Year Perspective for Infection Surveillance Solutions by Product - Percentage Breakdown of Value Sales for Software and Services for the Years 2020 & 2027
  • Table 15: USA Current & Future Analysis for Infection Surveillance Solutions by End-Use - Hospitals, Long-term Care Facilities and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • Table 16: USA 7-Year Perspective for Infection Surveillance Solutions by End-Use - Percentage Breakdown of Value Sales for Hospitals, Long-term Care Facilities and Other End-Uses for the Years 2020 & 2027
  • Active Players in Canada
  • Table 17: Canada Current & Future Analysis for Infection Surveillance Solutions by Product - Software and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • Table 18: Canada 7-Year Perspective for Infection Surveillance Solutions by Product - Percentage Breakdown of Value Sales for Software and Services for the Years 2020 & 2027
  • Table 19: Canada Current & Future Analysis for Infection Surveillance Solutions by End-Use - Hospitals, Long-term Care Facilities and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • Table 20: Canada 7-Year Perspective for Infection Surveillance Solutions by End-Use - Percentage Breakdown of Value Sales for Hospitals, Long-term Care Facilities and Other End-Uses for the Years 2020 & 2027
  • Active Players in Japan
  • Table 21: Japan Current & Future Analysis for Infection Surveillance Solutions by Product - Software and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • Table 22: Japan 7-Year Perspective for Infection Surveillance Solutions by Product - Percentage Breakdown of Value Sales for Software and Services for the Years 2020 & 2027
  • Table 23: Japan Current & Future Analysis for Infection Surveillance Solutions by End-Use - Hospitals, Long-term Care Facilities and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • Table 24: Japan 7-Year Perspective for Infection Surveillance Solutions by End-Use - Percentage Breakdown of Value Sales for Hospitals, Long-term Care Facilities and Other End-Uses for the Years 2020 & 2027
  • Active Players in China
  • Table 25: China Current & Future Analysis for Infection Surveillance Solutions by Product - Software and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • Table 26: China 7-Year Perspective for Infection Surveillance Solutions by Product - Percentage Breakdown of Value Sales for Software and Services for the Years 2020 & 2027
  • Table 27: China Current & Future Analysis for Infection Surveillance Solutions by End-Use - Hospitals, Long-term Care Facilities and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • Table 28: China 7-Year Perspective for Infection Surveillance Solutions by End-Use - Percentage Breakdown of Value Sales for Hospitals, Long-term Care Facilities and Other End-Uses for the Years 2020 & 2027
  • Table 29: Europe Current & Future Analysis for Infection Surveillance Solutions by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
  • Table 30: Europe 7-Year Perspective for Infection Surveillance Solutions by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2020 & 2027
  • Table 31: Europe Current & Future Analysis for Infection Surveillance Solutions by Product - Software and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • Table 32: Europe 7-Year Perspective for Infection Surveillance Solutions by Product - Percentage Breakdown of Value Sales for Software and Services for the Years 2020 & 2027
  • Table 33: Europe Current & Future Analysis for Infection Surveillance Solutions by End-Use - Hospitals, Long-term Care Facilities and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • Table 34: Europe 7-Year Perspective for Infection Surveillance Solutions by End-Use - Percentage Breakdown of Value Sales for Hospitals, Long-term Care Facilities and Other End-Uses for the Years 2020 & 2027
  • Active Players in France
  • Table 35: France Current & Future Analysis for Infection Surveillance Solutions by Product - Software and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • Table 36: France 7-Year Perspective for Infection Surveillance Solutions by Product - Percentage Breakdown of Value Sales for Software and Services for the Years 2020 & 2027
  • Table 37: France Current & Future Analysis for Infection Surveillance Solutions by End-Use - Hospitals, Long-term Care Facilities and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • Table 38: France 7-Year Perspective for Infection Surveillance Solutions by End-Use - Percentage Breakdown of Value Sales for Hospitals, Long-term Care Facilities and Other End-Uses for the Years 2020 & 2027
  • Active Players in Germany
  • Table 39: Germany Current & Future Analysis for Infection Surveillance Solutions by Product - Software and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • Table 40: Germany 7-Year Perspective for Infection Surveillance Solutions by Product - Percentage Breakdown of Value Sales for Software and Services for the Years 2020 & 2027
  • Table 41: Germany Current & Future Analysis for Infection Surveillance Solutions by End-Use - Hospitals, Long-term Care Facilities and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • Table 42: Germany 7-Year Perspective for Infection Surveillance Solutions by End-Use - Percentage Breakdown of Value Sales for Hospitals, Long-term Care Facilities and Other End-Uses for the Years 2020 & 2027
  • Active Players in Italy
  • Table 43: Italy Current & Future Analysis for Infection Surveillance Solutions by Product - Software and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • Table 44: Italy 7-Year Perspective for Infection Surveillance Solutions by Product - Percentage Breakdown of Value Sales for Software and Services for the Years 2020 & 2027
  • Table 45: Italy Current & Future Analysis for Infection Surveillance Solutions by End-Use - Hospitals, Long-term Care Facilities and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • Table 46: Italy 7-Year Perspective for Infection Surveillance Solutions by End-Use - Percentage Breakdown of Value Sales for Hospitals, Long-term Care Facilities and Other End-Uses for the Years 2020 & 2027
  • Active Players in United Kingdom
  • Table 47: UK Current & Future Analysis for Infection Surveillance Solutions by Product - Software and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • Table 48: UK 7-Year Perspective for Infection Surveillance Solutions by Product - Percentage Breakdown of Value Sales for Software and Services for the Years 2020 & 2027
  • Table 49: UK Current & Future Analysis for Infection Surveillance Solutions by End-Use - Hospitals, Long-term Care Facilities and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • Table 50: UK 7-Year Perspective for Infection Surveillance Solutions by End-Use - Percentage Breakdown of Value Sales for Hospitals, Long-term Care Facilities and Other End-Uses for the Years 2020 & 2027
  • Active Players in Rest of Europe
  • Table 51: Rest of Europe Current & Future Analysis for Infection Surveillance Solutions by Product - Software and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • Table 52: Rest of Europe 7-Year Perspective for Infection Surveillance Solutions by Product - Percentage Breakdown of Value Sales for Software and Services for the Years 2020 & 2027
  • Table 53: Rest of Europe Current & Future Analysis for Infection Surveillance Solutions by End-Use - Hospitals, Long-term Care Facilities and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • Table 54: Rest of Europe 7-Year Perspective for Infection Surveillance Solutions by End-Use - Percentage Breakdown of Value Sales for Hospitals, Long-term Care Facilities and Other End-Uses for the Years 2020 & 2027
  • Active Players in Asia-Pacific
  • Table 55: Asia-Pacific Current & Future Analysis for Infection Surveillance Solutions by Product - Software and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • Table 56: Asia-Pacific 7-Year Perspective for Infection Surveillance Solutions by Product - Percentage Breakdown of Value Sales for Software and Services for the Years 2020 & 2027
  • Table 57: Asia-Pacific Current & Future Analysis for Infection Surveillance Solutions by End-Use - Hospitals, Long-term Care Facilities and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • Table 58: Asia-Pacific 7-Year Perspective for Infection Surveillance Solutions by End-Use - Percentage Breakdown of Value Sales for Hospitals, Long-term Care Facilities and Other End-Uses for the Years 2020 & 2027
  • Active Players in Rest of World
  • Table 59: Rest of World Current & Future Analysis for Infection Surveillance Solutions by Product - Software and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • Table 60: Rest of World 7-Year Perspective for Infection Surveillance Solutions by Product - Percentage Breakdown of Value Sales for Software and Services for the Years 2020 & 2027
  • Table 61: Rest of World Current & Future Analysis for Infection Surveillance Solutions by End-Use - Hospitals, Long-term Care Facilities and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • Table 62: Rest of World 7-Year Perspective for Infection Surveillance Solutions by End-Use - Percentage Breakdown of Value Sales for Hospitals, Long-term Care Facilities and Other End-Uses for the Years 2020 & 2027
IV. COMPETITION
  • Total Companies Profiled: 41
Note: Product cover images may vary from those shown
Adroll
adroll